You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Science

science in mind

Key to curing Alzheimer’s may be changing drug development funding

MIT economist calls for Alzheimer’s ‘megafund’

Based on the current rates of success in creating new drugs for Alzheimer’s disease, it could take 260 years until the next one is approved, according to an analysis led by a Massachusetts Institute of Technology economist.

That depressing prediction, published in the journal Science Translational Medicine on Wednesday, is based on a model that presumes the current strategy for drug development continues. That consists largely of developing and testing drugs, one by one, that act on one particular target, the build up of beta-amyloid protein in the brain.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week